Loading...

Tom Bersot, MD, PhD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address1650 Owens Street
San Francisco CA 94158
Phone415-734-2027
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency School of Medicine

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat. J Clin Endocrinol Metab. 2015 Jun; 100(6):2434-42. Schwarz JM, Noworolski SM, Wen MJ, Dyachenko A, Prior JL, Weinberg ME, Herraiz LA, Tai VW, Bergeron N, Bersot TP, Rao MN, Schambelan M, Mulligan K. PMID: 25825943.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCellsCTClinical Trials
    2. [Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary]. Clin Investig Arterioscler. 2014 Jan-Feb; 26(1):33-7. Grundy SM, Arai H, Barter P, Bersot TP, Betteridge DJ, Carmena R, Cuevas A, Davidson MH, Genest J, Kesäniemi YA, Sadikot S, Santos RD, Susekov A, Sy R, Tokgozoglu L, Watts GF, Zhao D. PMID: 24169377.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Optimal waist:height ratio cut-off point for cardiometabolic risk factors in Turkish adults. Public Health Nutr. 2010 Apr; 13(4):488-95. Can AS, Yildiz EA, Samur G, Rakicioglu N, Pekcan G, Ozbayrakçi S, Palaoglu KE, Gönen M, Bersot TP. PMID: 19781128.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    4. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity (Silver Spring). 2009 Apr; 17(4):737-44. Ling H, Waterworth DM, Stirnadel HA, Pollin TI, Barter PJ, Kesäniemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP, Cohen JC, Grundy SM, Mooser VE, Mitchell BD. PMID: 19165155.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    5. Comparison between Turkish Cardiovascular Risk Platform and United States National Cholesterol Education Program Adult Treatment Panel III definitions of the metabolic syndrome in Turkish adults. J Cardiometab Syndr. 2009; 4(1):26-32. Can AS, Ozbayrakçi S, Palaoglu KE, Bersot TP. PMID: 19245513.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Anthropometric indices and their relationship with cardiometabolic risk factors in a sample of Turkish adults. Public Health Nutr. 2009 Apr; 12(4):538-46. Can AS, Bersot TP, Gönen M, Pekcan G, Rakicioglu N, Samur G, Yildiz EA. PMID: 18489811.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    7. Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study. BMC Public Health. 2007 Dec 19; 7:353. Can AS, Bersot TP. PMID: 18088443.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    8. Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study. Atherosclerosis. 2008 Apr; 197(2):868-76. Stirnadel H, Lin X, Ling H, Song K, Barter P, Kesäniemi YA, Mahley R, McPherson R, Waeber G, Bersot T, Cohen J, Grundy S, Mitchell B, Mooser V, Waterworth D. PMID: 17888929.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    9. Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia. J Clin Endocrinol Metab. 2007 Jun; 92(6):2041-5. Barter P, McPherson YR, Song K, Kesäniemi YA, Mahley R, Waeber G, Bersot T, Mooser V, Waterworth D, Grundy SM. PMID: 17389699.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    10. Hypertriglyceridemia: management of atherogenic dyslipidemia. J Fam Pract. 2006 Jul; 55(7):S1-8. Bersot T, Haffner S, Harris WS, Kellick KA, Morris CM. PMID: 16822443.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    11. High density lipoprotein cholesterol in coronary artery patients: is it as low as expected? Anadolu Kardiyol Derg. 2006 Mar; 6(1):94-6; author reply 96. Mahley RW, Bersot TP. PMID: 16524816.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Modulation of high-density lipoproteins in a population in istanbul, Turkey, with low levels of high-density lipoproteins. Am J Cardiol. 2005 Aug 15; 96(4):547-55. Mahley RW, Can S, Ozbayrakçi S, Bersot TP, Tanir S, Palaoglu KE, Pépin GM. PMID: 16098310.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    13. Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia. J Lipid Res. 2005 Oct; 46(10):2202-13. Yu Y, Wyszynski DF, Waterworth DM, Wilton SD, Barter PJ, Kesäniemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP, Ma Q, Sharma SS, Montgomery DS, Middleton LT, Sundseth SS, Mooser V, Grundy SM, Farrer LA. PMID: 16061952.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    14. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol. 2005 Jan 15; 95(2):194-8. Wyszynski DF, Waterworth DM, Barter PJ, Cohen J, Kesäniemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP, Sharma SS, Nolan V, Middleton LT, Sundseth SS, Farrer LA, Mooser V, Grundy SM. PMID: 15642551.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    15. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol. Am Heart J. 2003 Dec; 146(6):1052-9. Bersot TP, Pépin GM, Mahley RW. PMID: 14660998.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    16. Antibody phenotyping test for the human apolipoprotein E2 isoform. Clin Chem. 2003 Sep; 49(9):1524-6. Raffaï RL, McPherson R, Weisgraber KH, Innerarity TL, Rassart E, Bersot TP, Milne RW. PMID: 12928236.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Managing dyslipidemia in Turkey: suggested guidelines for a population characterized by low levels of high density lipoprotein cholesterol. Anadolu Kardiyol Derg. 2002 Dec; 2(4):315-22. Bersot TP, Palaoglu KE, Mahley RW. PMID: 12460830.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. Sources of variability in genetic association studies: insights from the analysis of hepatic lipase (LIPC). Hum Mutat. 2002 May; 19(5):536-42. Shohet RV, Vega GL, Bersot TP, Mahley RW, Grundy SM, Guerra R, Cohen JC. PMID: 11968086.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    19. Plasma lipids in Turkish children: impact of puberty, socioeconomic status, and nutrition on plasma cholesterol and HDL. J Lipid Res. 2001 Dec; 42(12):1996-2006. Mahley RW, Arslan P, Pekcan G, Pépin GM, Agaçdiken A, Karaagoglu N, Rakicioglu N, Nursal B, Dayanikli P, Palaoglu KE, Bersot TP. PMID: 11734572.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    20. Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase. High density lipoprotein characterization and gender-specific effects of apolipoprotein e genotype. J Lipid Res. 2000 Aug; 41(8):1290-301. Mahley RW, Pépin J, Palaoglu KE, Malloy MJ, Kane JP, Bersot TP. PMID: 10946017.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    21. Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population. J Lipid Res. 1999 Mar; 40(3):432-8. Bersot TP, Vega GL, Grundy SM, Palaoglu KE, Atagündüz P, Ozbayrakçi S, Gökdemir O, Mahley RW. PMID: 10064731.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    22. The -514 polymorphism in the hepatic lipase gene (LIPC) does not influence androgen-mediated stimulation of hepatic lipase activity. J Lipid Res. 1998 Jul; 39(7):1520-4. Vega GL, Gao J, Bersot TP, Mahley RW, Verstraete R, Grundy SM, White A, Cohen JC. PMID: 9684756.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    23. A unique haplotype of the apolipoprotein B-100 allele associated with familial defective apolipoprotein B-100 in a Chinese man discovered during a study of the prevalence of this disorder. J Lipid Res. 1993 Jul; 34(7):1149-54. Bersot TP, Russell SJ, Thatcher SR, Pomernacki NK, Mahley RW, Weisgraber KH, Innerarity TL, Fox CS. PMID: 8371062.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    24. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res. 1990 Aug; 31(8):1337-49. Innerarity TL, Mahley RW, Weisgraber KH, Bersot TP, Krauss RM, Vega GL, Grundy SM, Friedl W, Davignon J, McCarthy BJ. PMID: 2280177.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    25. Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant. J Clin Invest. 1989 Apr; 83(4):1095-101. Rall SC, Newhouse YM, Clarke HR, Weisgraber KH, McCarthy BJ, Mahley RW, Bersot TP. PMID: 2539388.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    26. Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages. J Clin Invest. 1986 Feb; 77(2):622-30. Bersot TP, Innerarity TL, Pitas RE, Rall SC, Weisgraber KH, Mahley RW. PMID: 2935560.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    27. Type III hyperlipoproteinemia: a focus on lipoprotein receptor-apolipoprotein E2 interactions. Adv Exp Med Biol. 1986; 201:273-88. Innerarity TL, Hui DY, Bersot TP, Mahley RW. PMID: 3026150.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    28. Purification and characterization of human lipoprotein lipase and hepatic triglyceride lipase. Reactivity with monoclonal antibodies to hepatic triglyceride lipase. J Biol Chem. 1985 Sep 05; 260(19):10720-7. Cheng CF, Bensadoun A, Bersot T, Hsu JS, Melford KH. PMID: 4030767.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    29. Receptor binding activity of high-density lipoproteins containing apoprotein E from abetalipoproteinemic and normal neonate plasma. Metabolism. 1984 Feb; 33(2):186-95. Innerarity TL, Bersot TP, Arnold KS, Weisgraber KH, Davis PA, Forte TM, Mahley RW. PMID: 6319954.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    30. Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype. J Clin Invest. 1983 Oct; 72(4):1288-97. Rall SC, Weisgraber KH, Innerarity TL, Bersot TP, Mahley RW, Blum CB. PMID: 6313758.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    31. Cholesteryl ester accumulation in mouse peritoneal macrophages induced by beta-migrating very low density lipoproteins from patients with atypical dysbetalipoproteinemia. J Clin Invest. 1983 Sep; 72(3):1024-33. Bersot TP, Innerarity TL, Mahley RW, Havel RJ. PMID: 6309903.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    32. Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3. J Clin Invest. 1983 Jul; 72(1):379-87. Havel RJ, Kotite L, Kane JP, Tun P, Bersot T. PMID: 6860421.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimals
    33. Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I. J Biol Chem. 1983 Feb 25; 258(4):2508-13. Weisgraber KH, Rall SC, Bersot TP, Mahley RW, Franceschini G, Sirtori CR. PMID: 6401735.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    34. A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins. J Clin Invest. 1980 Nov; 66(5):901-7. Weisgraber KH, Bersot TP, Mahley RW, Franceschini G, Sirtori CR. PMID: 6776144.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    35. Isolation and characterization of an apoprotein from the d less than 1.006 lipoproteins of human and canine lymph homologous with the rat A-IV apoprotein. Biochem Biophys Res Commun. 1978 Nov 14; 85(1):287-92. Weisgraber KH, Bersot TP, Mahley RW. PMID: 217374.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    36. Alterations in human high-density lipoproteins, with or without increased plasma-cholesterol, induced by diets high in cholesterol. Lancet. 1978 Oct 14; 2(8094):807-9. Mahley RW, Innerarity TL, Bersot TP, Lipson A, Margolis S. PMID: 81362.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    37. Apoprotein (E--A-II) complex of human plasma lipoproteins. II. Receptor binding activity of a high density lipoprotein subfraction modulated by the apo(E--A-II) complex. J Biol Chem. 1978 Sep 10; 253(17):6289-95. Innerarity TL, Mahley RW, Weisgraber KH, Bersot TP. PMID: 210175.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    38. Interaction of swine lipoproteins with the low density lipoprotein receptor in human fibroblasts. J Biol Chem. 1976 Apr 25; 251(8):2395-8. Bersot TP, Mahley RW, Brown MS, Goldstein JL. PMID: 177413.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    39. Characterization of the rat apolipoproteins. I. The low molecular weight proteins of rat plasma high density lipoproteins. J Biol Chem. 1974 Sep 25; 249(18):5718-24. Herbert PN, Windmueller HG, Bersot TP, Shulman RS. PMID: 4369853.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    40. Identity of very low density lipoprotein apoproteins of plasma and liver Golgi apparatus. Science. 1970 Apr 17; 168(3929):380-2. Mahley RW, Bersot TP, LeQuire VS, Levy RI, Windmueller HG, Brown WV. PMID: 4985196.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    Tom's Networks
    Concepts (229)
    Derived automatically from this person's publications.
    _
    Co-Authors (12)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _